Tobacco use and surgical outcomes in patients with head and neck cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 25521527.
- Also identified by DOI 10.1002/hed.23944 and PMC identifier 4472632.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tobacco use is a risk factor for head and neck cancer, but effects on postoperative outcomes are unclear. Patients with head and neck cancer (n = 89) were recruited before surgery. We assessed self-reported tobacco use status (never, former, or current) at study entry and recent tobacco exposure via urinary cotinine on surgery day. Outcomes included hospital length of stay (LOS) and complications. Most participants reported current (32.6%) or former (52.8%) tobacco use; 43.2% were cotinine-positive on surgery day. Complications occurred in 41.6% and mean LOS was 4.0 and 8.8 days in patients who received low and high acuity procedures, respectively. Current and former smokers were over 6 times more likely to have complications than never smokers (p = .03). For high acuity procedures, LOS was increased in current (by 4.4 days) and former smokers (by 2.3 days; p = .02). Tobacco use status is associated with postoperative complications and may distinguish at-risk patients.
Medical subject headings
- Head and Neck Neoplasms
- Postoperative Complications
- Tobacco Use